NAC (N-acetylcysteine) has been used safely in clinical trials lasting up to three years, making it one of the better-studied supplements for extended use. The longest controlled study, known as the BRONCUS trial, gave 256 people 600 mg of NAC daily for three years and found no adverse events that were attributed to the drug itself. That said, most research still tops out at 6 to 12 months, and what counts as “long term” depends on your dose and the reason you’re taking it.
What the Longest Studies Show
The strongest safety data comes from respiratory disease research, where NAC has been studied for years rather than weeks. In the three-year BRONCUS trial, the rate of side effects in the NAC group was essentially identical to the placebo group: 1,428 adverse events were reported with NAC versus 1,381 with placebo, and none were considered drug-related. Only 9% of the NAC group reported issues potentially linked to the supplement, primarily stomach pain, nausea, and indigestion.
Multiple 12-month trials in COPD and bronchiectasis patients paint a similar picture. Across studies enrolling nearly 1,000 participants on 1,200 mg per day, gastrointestinal complaints remained the most common side effect, affecting roughly 6 to 10% of users. These were mild enough that dropout rates in NAC groups were comparable to placebo groups. One 60-week trial using a higher dose of 1,800 mg per day in patients with idiopathic pulmonary fibrosis also showed a manageable side effect profile, with 18.8% reporting adverse events and zero gastrointestinal complaints.
Typical Doses and How They Vary by Purpose
The dose people take long term varies considerably depending on the goal. For general antioxidant support and respiratory health, 600 mg once or twice daily is the most commonly studied range. A meta-analysis of COPD research noted that doses of 1,200 mg per day or higher are needed for meaningful antioxidant activity in those patients.
In psychiatric research, doses run much higher. Trials for OCD have used 2,000 to 3,000 mg per day, typically for 10 to 16 weeks. Bipolar disorder studies have tested 2,000 mg daily for up to 24 weeks. One schizophrenia trial used 3,600 mg per day for a full year, the highest chronic dose in published research. These psychiatric trials tend to be shorter than the respiratory studies, so long-term safety data at these higher doses is more limited.
For hormonal and metabolic health, particularly in women with PCOS, doses of 1,200 to 1,800 mg daily have been studied for 6 to 24 weeks. Results showed improvements in blood sugar, insulin levels, and BMI, with benefits appearing to increase with longer use. One comparison found NAC outperformed metformin on several metabolic markers after 24 weeks. Researchers have noted, though, that safety data beyond 24 weeks in this population is still lacking.
The Most Common Side Effects
Across nearly all long-term trials, the side effect profile is dominated by GI symptoms: stomach discomfort, nausea, and occasional diarrhea. These tend to be mild and often resolve on their own. In the large PANTHEON trial of nearly 1,000 participants, only 9% of those on NAC reported any side effects at all over 12 months.
A few less common effects have been documented in individual studies. Body odor was reported by about 6% of participants in one bronchiectasis trial. Mild skin rash appeared in roughly 2.5% of that same group. A small number of participants (3.7%) showed changes in liver function markers, though other research has actually found NAC improves liver enzyme levels. In a six-month trial of patients with cirrhosis, NAC significantly reduced markers of liver stress and also improved kidney function markers.
Theoretical Risks Worth Knowing About
One concern that circulates online is the risk of pulmonary arterial hypertension. This comes from a mouse study published in the Journal of Clinical Investigation, which found that chronic NAC administration caused increased pressure in the blood vessels of the lungs, mimicking the effects of oxygen deprivation. The finding is real but comes with important context: the dose used in mice was higher than what humans typically take, and this effect has never been observed in any human trial, including the three-year BRONCUS study. The researchers themselves noted the dose discrepancy was “reassuring,” while still recommending surveillance in long-term human trials.
Another potential concern is mineral balance. NAC can bind to copper and zinc due to its chemical structure, and a 20-week mouse study found reduced copper levels in the liver and spleen, with smaller reductions in zinc. The effects were described as “rather small,” and no equivalent human data exists. Still, if you’re taking NAC for months or years, it’s reasonable to ensure your diet includes adequate sources of these minerals.
Interactions With Medications
NAC has one well-documented and clinically significant interaction: it amplifies the blood-pressure-lowering effects of nitroglycerin, a medication used for angina and heart conditions. In a clinical study combining the two, seven patients experienced symptomatic drops in blood pressure compared to zero in the control group. NAC enhances nitroglycerin’s ability to dilate blood vessels and also strongly inhibits blood clotting through the formation of a combined compound. If you take nitroglycerin or other nitrate medications, NAC is not a casual addition.
Because NAC boosts your body’s production of glutathione, the liver’s primary detoxification molecule, it can theoretically alter how quickly your liver processes certain drugs. This is most relevant for people on medications with narrow dosing windows, where small changes in metabolism could matter.
Regulatory Status in the U.S.
NAC occupies an unusual legal gray area. The FDA has determined that it technically doesn’t qualify as a dietary supplement because it was approved as a pharmaceutical drug before it was ever sold as a supplement. However, the agency issued a final guidance stating it will exercise “enforcement discretion,” allowing NAC supplements to remain on the market while it considers formal rulemaking to resolve the issue. In practice, NAC is widely available and sold by most major supplement brands, though this could change depending on how the FDA’s rulemaking process concludes.
Practical Takeaways for Long-Term Use
At 600 mg per day, NAC has a three-year safety track record in controlled research with a side effect profile comparable to placebo. At 1,200 mg per day, safety data extends to about 12 months across multiple large trials, with mild digestive symptoms as the primary complaint in under 10% of users. Above 1,800 mg per day, the research is shorter in duration (typically under a year) and concentrated in psychiatric populations.
If you’re considering NAC for ongoing use, starting at a lower dose and working up can help minimize stomach-related side effects. Taking it with food also helps. The supplement appears to be genuinely well tolerated over extended periods for most people, but the strongest evidence for multi-year safety exists only at the 600 mg daily dose. Anything above that for longer than a year is moving beyond where the clinical data can firmly reassure you.